Literature DB >> 29360888

Direct and indirect patient costs of dermatology clinic visits and their impact on access to care and provider preference.

Brooke E Rothstein1, Jessica Gonzalez1, Kiera Cunningham2, Ami Saraiya3, Adriana C Dornelles4, Bichchau M Nguyen2.   

Abstract

The direct and indirect costs of dermatology clinic visits are infrequently quantified. Indirect costs, such as the time spent traveling to and from appointments and the value of lost earnings from time away from work, are substantial costs that often are not included in economic analyses but may pose barriers to receiving care. Due to the national shortage of dermatologists, patients may have to wait longer for appointments or travel further to see dermatologists outside of their local community, resulting in high time and travel costs for patients. Patients' lost time and earnings comprise the opportunity cost of obtaining care. A monetary value for this opportunity cost can be calculated by multiplying a patient's hourly wage by the number of hours that the patient dedicated to attending the dermatology appointment. Using a single institution survey, this study quantified the direct and indirect patient costs, including opportunity costs and time burden, associated with dermatology clinic visits to better appreciate the impact of these factors on health care access and dermatologic provider preference.

Entities:  

Mesh:

Year:  2017        PMID: 29360888

Source DB:  PubMed          Journal:  Cutis        ISSN: 0011-4162


  2 in total

1.  Financial stress among skin cancer patients: a cross-sectional review of the 2013-2018 National Health Interview Survey.

Authors:  Thomas B Cwalina; Tarun K Jella; Raghav Tripathi; Bryan T Carroll
Journal:  Arch Dermatol Res       Date:  2022-02-22       Impact factor: 3.017

2.  Health Economic Consequences of a Tightly Controlled Dose Reduction Strategy for Adalimumab, Etanercept and Ustekinumab Compared with Standard Psoriasis Care: A Cost-utility Analysis of the CONDOR Study.

Authors:  Selma Atalay; Juul M P A van den Reek; Marisol E Otero; Marcellus D Njoo; Johannes M Mommers; Paul M Ossenkoppele; Marjolein I Koetsier; Maartje M Berends; Peter C M van de Kerkhof; Hans M M Groenewoud; Alfons A den Broeder; Elke M G J de Jong; Wietske Kievit
Journal:  Acta Derm Venereol       Date:  2020-12-01       Impact factor: 3.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.